sb 203580 has been researched along with picibanil in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (picibanil) | Trials (picibanil) | Recent Studies (post-2010) (picibanil) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 1,602 | 149 | 143 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, W; Li, JJ; Liang, XT; Liu, WL; Pan, K; Sun, JC; Wang, H; Weng, DS; Xia, JC; Zhang, HK; Zhou, J | 1 |
1 other study(ies) available for sb 203580 and picibanil
Article | Year |
---|---|
The pivotal role of p38 and NF-kappaB signal pathways in the maturation of human monocyte-derived dendritic cells stimulated by streptococcal agent OK-432.
Topics: B7-1 Antigen; Cell Differentiation; Cells, Cultured; Chemokine CXCL10; Dendritic Cells; Humans; Imidazoles; Interleukin-12; Lymphocyte Activation; NF-kappa B; Nitriles; p38 Mitogen-Activated Protein Kinases; Picibanil; Pyridines; Signal Transduction; Streptococcus; Sulfones; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2009 |